|  Help  |  About  |  Contact Us

Publication : HIPK2 is necessary for type I interferon-mediated antiviral immunity.

First Author  Cao L Year  2019
Journal  Sci Signal Volume  12
Issue  573 PubMed ID  30890658
Mgi Jnum  J:283512 Mgi Id  MGI:6380998
Doi  10.1126/scisignal.aau4604 Citation  Cao L, et al. (2019) HIPK2 is necessary for type I interferon-mediated antiviral immunity. Sci Signal 12(573)
abstractText  Precise control of interferons (IFNs) is crucial to maintain immune homeostasis. Here, we demonstrated that homeodomain-interacting protein kinase 2 (HIPK2) was required for the production of type I IFNs in response to RNA virus infection. HIPK2 deficiency markedly impaired IFN production in macrophages after vesicular stomatitis virus (VSV) infection, and HIPK2-deficient mice were more susceptible to lethal VSV disease than were wild-type mice. After VSV infection, HIPK2 was cleaved by active caspases, which released a hyperactive, N-terminal fragment that translocated to the nucleus and further augmented antiviral responses. In part, HIPK2 interacted with ELF4 and promoted its phosphorylation at Ser(369), which enabled Ifn-b transcription. In addition, HIPK2 production was stimulated by type I IFNs to further enhance antiviral immunity. These data suggest that the kinase activity and nuclear localization of HIPK2 are essential for the production of type I IFNs.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

6 Bio Entities

Trail: Publication

0 Expression